Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • Page 8
middle-aged-men-face-accelerated-aging-linked-to-‘forever-chemicals’
Posted inBiotechnology

Middle-Aged Men Face Accelerated Aging Linked to ‘Forever Chemicals’

February 26, 2026
Per- and polyfluoroalkyl substances, commonly known as PFAS or ‘forever chemicals,’ have long captured the attention of environmental scientists and…
Read More
billion-dkk-funding-boosts-green-transformation-research-in-built-environment
Posted inBiotechnology

Billion-DKK Funding Boosts Green Transformation Research in Built Environment

February 26, 2026
The construction industry accounts for an astonishing 37 percent of global CO2 emissions, positioning it as a critical sector in…
Read More
voices-from-the-heart:-new-study-highlights-parenting-challenges-in-early-onset-cardiovascular-disease
Posted inBiotechnology

Voices from the Heart: New Study Highlights Parenting Challenges in Early-Onset Cardiovascular Disease

February 26, 2026
As the incidence of early-onset cardiovascular disease escalates across the globe, a lesser-explored dimension of this emerging health crisis is…
Read More
rare-coral-reef-ecosystems:-nature’s-vanishing-pharmacy
Posted inBiotechnology

Rare Coral Reef Ecosystems: Nature’s Vanishing Pharmacy

February 26, 2026
Coral reefs represent some of the most biologically rich ecosystems on our planet, occupying less than one percent of the…
Read More
accent-halts-solid-tumor-trial-over-adverse-events,-pivots-to-other-lead-cancer-program
Posted inBiotechnology

Accent halts solid tumor trial over adverse events, pivots to other lead cancer program

February 26, 2026
Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 study. The…
Read More
tirzepatide-adverse-events:-subgroup-differences-explored
Posted inBiotechnology

Tirzepatide Adverse Events: Subgroup Differences Explored

February 26, 2026
In the rapidly evolving landscape of diabetes treatment, tirzepatide has emerged as a novel and potent therapeutic agent, heralded for…
Read More
sel1l-hrd1-erad-boosts-glucagon-in-islet-α-cells
Posted inBiotechnology

SEL1L-HRD1 ERAD Boosts Glucagon in Islet α Cells

February 26, 2026
In a groundbreaking study poised to reshape our understanding of cellular protein regulation, researchers Zhu, Pan, Cui, and their team…
Read More
scientists-develop-distortion-resistant-materials-to-enhance-lithium-ion-battery-performance
Posted inBiotechnology

Scientists Develop Distortion-Resistant Materials to Enhance Lithium-Ion Battery Performance

February 26, 2026
In the ongoing quest to produce more efficient, cost-effective, and environmentally sustainable battery technologies, a groundbreaking study has recently emerged…
Read More
research-shows-exercise-during-chemotherapy-significantly-enhances-quality-of-life-for-breast-cancer-patients
Posted inBiotechnology

Research Shows Exercise During Chemotherapy Significantly Enhances Quality of Life for Breast Cancer Patients

February 26, 2026
In a groundbreaking meta-analysis published in The Lancet Healthy Longevity, researchers led by the Sylvester Comprehensive Cancer Center at the…
Read More
unexpected-factor-behind-chronic-rejection-in-lung-and-heart-transplants-uncovered
Posted inBiotechnology

Unexpected Factor Behind Chronic Rejection in Lung and Heart Transplants Uncovered

February 26, 2026
In a groundbreaking revelation that challenges long-held beliefs in organ transplantation, researchers at Washington University School of Medicine in St.…
Read More

Posts pagination

Previous page 1 … 6 7 8 9 10 … 293 Next page

Privacy Policy    Terms

Scroll to Top